InvestorsHub Logo
Followers 827
Posts 119480
Boards Moderated 15
Alias Born 09/05/2002

Re: None

Thursday, 08/08/2019 4:25:02 PM

Thursday, August 08, 2019 4:25:02 PM

Post# of 291
Hmm…

https://finance.yahoo.com/news/nektar-therapeutics-reports-financial-results-201500243.html

Nektar is hosting a conference call with analysts and investors today on which it will discuss quarterly results. On the call, the company will provide a specific update and discussion on its bempegaldesleukin clinical development program, including recent developments related to the manufacturing of bempegaldesleukin.

Bempegaldesleukin is f/k/a NKTR-214.

The stock is currently halted. CC at 5pm ET.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NKTR News